MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility ...

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK), (“ReWalk” or the “Company”), a leading provider of innovative technologies that ...

Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments.

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...

Lifeward signs contractual agreement with BARMER, Germany’s second largest statutory health insurance company, to streamline access to ReWalk Personal Exoskeletons for eligible beneficiaries Following ...

Reynolds’s exoskeleton technology, called the ReWalk 7, helps her stand and walk by propelling her forward. Medicare has ...

Proposed benefit category assignment represents a positive step in facilitating Medicare coverage of personal exoskeletons for qualified individuals with spinal cord injury (SCI). ReWalk Robotics is ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that ...

Lifeward Ltd. LFWD recently announced that it has received CE mark approval for the ReWalk 7 Personal Exoskeleton. Following this approval, the seventh generation of the ReWalk is now cleared for ...